SecBot SecBot
PRESS-RELEASE ·Filed Nov 4, 2026

PGNY

Progyny, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed12d 7h ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ▲ Bullish

The record selling season and raised guidance signal strong momentum into 2027. Monitor Q4 2026 results for member engagement and the pace of new client launches, as well as the February 2027 guidance for 2027.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$34.37
T+0 close · Nov 4, 2026 · via day close
Latest settled
+6.43%
T+5 · $36.58 · next T+20 in 17d
Vs SPY
+3.14%
α at T+5
Latest observation
+5.70%
T+6 · FF3 residual α
  1. T+0 · Nov 5 $34.37entry
  2. T+1 · 11d ago +1.37%α +1.06% · $34.84
  3. T+5 · 5d ago +6.43%α +3.14% · $36.58
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Progyny reported Q3 2026 revenue of $341.3M (+8.9% YoY) and adjusted EPS of $0.52, beating the $0.51 consensus. The company raised the midpoint of its full-year 2026 revenue guidance to $1.365B-$1.385B and adjusted EPS to $2.09-$2.13, driven by a record selling season adding 1.3M new covered lives and near-100% retention.

Key Financial Metrics

EPS (Adj.)
$0.52
est $0.51 · +2.0% · GAAP: $0.32
Revenue
$341.3M
est $340.8M · +0.1% · +8.9% YoY
Rating
in line
Guidance
$1.365B-$1.385B
raised
Gross Margin
24.5%

Key Facts

  • Q3 2026 revenue $341.3M, +8.9% YoY, vs consensus $340.8M
  • Q3 2026 adjusted EPS $0.52, vs consensus $0.51
  • GAAP diluted EPS $0.32, vs $0.15 YoY
  • Gross margin 24.5%, up from 23.2% YoY
  • Adjusted EBITDA $58.4M, +6.3% YoY; margin 17.1% vs 17.5% YoY
  • Record selling season: 1.3M new covered lives, 85+ new clients, near-100% retention
  • Full-year 2026 revenue guidance raised to $1.365B-$1.385B (midpoint $1.375B)
  • Full-year 2026 adjusted EPS guidance raised to $2.09-$2.13
  • Repurchased nearly 3M shares for $82.7M in Q3; $51M remaining under authorization
  • 607 clients as of Sep 30, 2026, up from 553 a year ago

Financial Impact

Revenue beat consensus by ~$0.5M; adjusted EPS beat by $0.01; full-year guidance midpoint raised by ~$10M on revenue and ~$0.02 on adjusted EPS

revenueadjusted EPSgross marginadjusted EBITDAclient countcovered lives

Segment Breakdown

SegmentRevenueGrowth
Fertility benefit services$223.4M+10.6%
Pharmacy benefit services$117.9M+5.8%

Risk Factors

  • Adjusted EBITDA margin declined slightly YoY (17.1% vs 17.5%) due to planned investments
  • Heavy share repurchase activity ($231.4M YTD) reduces share count but consumes cash
  • Dependence on large client retention; one client with ~300K members not reflected in utilization metrics

Market Snapshot

Exchange
Nasdaq
Sector
Services-Misc Health & Allied Services, NEC
Analyst Consensus
83% bullish (18 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3395762

Track record

26 reports on PGNY

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $36.75 Now $37.15 +1.09% settles Nov 23
  2. Nov 12, 20264d ago Insider Cluster Bearish 4/10 Entry $36.18 Now $37.15 −2.68% settles Nov 20
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $36.58 Now $37.15 +1.56% settles Nov 19
  4. Nov 10, 20266d ago 144 Neutral 3/10 Entry $36.50 Now $37.15 +1.78% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $36.43 Now $37.15 +1.98% settles Nov 17
  6. Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
  7. Nov 5, 202611d ago 144 Neutral 2/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
  8. Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
  9. Nov 4, 202612d ago 8-K Bullish 6/10 No price data
  10. Nov 4, 202612d ago Press Release Bullish 6/10 Viewing Entry $34.37 to $36.58 Now $37.15 +8.09% ▲ +6.43% +3.14% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens Wed (9h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026